AFYREN: NEOXY plant doubles sales to ~€1M as ramp hits 20% capacity
- NEOXY generated approximately €1 million in revenues in the first months of 2026, doubling FY 2025 revenues.
- Production reached several hundreds of tons of acids plus a substantial volume of associated fertilizers.
- Demonstrated production capacity has reached 20% of full capacity.
- Reliability and optimization work was launched during a scheduled technical shutdown in June 2026.
Operational update
AFYREN reports growing activity at the NEOXY plant in the first months of 2026, with production again reaching several hundreds of tons of acids and a substantial volume of associated fertilizers.
Industrial performance continued to improve and demonstrated production capacity has reached 20% of full capacity. Reliability and optimization work has been launched as planned during a scheduled technical shutdown in June 2026.
Production and sales
The combined output of acids and fertilizers generated total revenues of approximately €1 million for AFYREN NEOXY in early 2026, doubling the plant's FY 2025 revenues.
Planned works and commercial outlook
AFYREN says the plant is producing, shipping and invoicing at an increasing pace but remains far from full potential; ongoing optimization works are presented as a key driver for acceleration.
The company describes a positive commercial outlook for its bio-based acids and fertilizers, citing growing concerns over fossil resource availability and pricing as factors accelerating the shift to its products.
Source: AFYREN
